Using low-frequency laser radiation to help elderly patients’ recovery from an acute cerebral circulatory disorder of ischemic genesis
Abstract
BACKGROUND. The method of low-frequency magnetolaser therapy for elderly and senile patients is extensively applied in the early recovery period after an acute cerebral circulatory disorder (ACCD) of ischemic genesis. This is due to the fact that under the influence of the low-intensity energy of optical quantum generators, reparative processes are stimulated, micro- and macrocirculation in the cerebral vascular network and in the general bloodstream is improved along with the rheological properties of blood, the state of oxygenation and metabolism in biological tissues. OBJECTIVES. To apply the method of laser irradiation onto biologically active points and determine the effectiveness and tolerability of the method for elderly and senile patients.MATERIALS AND METHODS. The study involved 188 patients aged 65 to 82 years in their early recovery period after an ACCD of ischemic genesis. The exposure was performed by the «Ricta 04/4» device 3–4 weeks after the acute disease period.Each patient received daily treatments on biolocically active points located in the 4th intercostal space at the edge of the sternum, subclavian, supraclavicular, suboccipital fossa, frontal and temporal regions, paravertebral on both sides of the VII cervical vertebra. Additionally, the elbow bends or hamstring fossae of paretic limbs were irradiated individually every other day.The exposure frequency was 5 Hz and 50 Hz with the exposure time of 1 minute per zone. The number of biologically active…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.